Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-14
2000-05-02
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548203, C07D27724, A61K 31427
Patent
active
060573481
ABSTRACT:
Isomers of a cytotoxic compound isolated and purified from a marine cyanobacterium Lyngbya majuscula are disclosed. The compound, termed "curacin D", exhibits substantial biological activity against proliferating cells. Analogs of curacin A also are described, as are formulations that include curacin D and the curacin A analogs. The curacins A-D and analogs of curacin A exhibit antimitotic behavior.
REFERENCES:
Verdier-Pinard Mol. Pharm. 53(1) 62 1998, Jan. 1998.
Nagle et al., "Absolute Configuration of Curacin A, a Novel Antimitotic Agent from the Tropical Marine Cyanobacterium Lyngbya majuscula," Tetrahedron Letters, vol. 36, No. 8, pp. 1189-1192 (1995).
Falck John R.
Gerwick William H.
Marquez Brian L.
Gerstl Robert
Oregon State University
LandOfFree
Curacin A analogs exhibiting antiproliferative activity against does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Curacin A analogs exhibiting antiproliferative activity against , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Curacin A analogs exhibiting antiproliferative activity against will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594192